Guangzhou Zhiyi Pharmaceutics

Developer of second-generation probiotics

placeGuangzhou, Guangdong, China calendar_todayFounded 2013 groups150 employees language zypharm.com.cn

Innovation

7 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 43 times.

YearFilings
20181
20193
20221
20232

Investor mix

5 investors on record; lead investors include SDIC Venture Capital Management, Guangdong Investment.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%
Coming soon